Consun Pharmaceutical Group Limited (HKG:1681)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.04
-0.12 (-0.91%)
Sep 11, 2026, 4:08 PM HKT

HKG:1681 Statistics

Total Valuation

HKG:1681 has a market cap or net worth of HKD 11.04 billion. The enterprise value is 7.01 billion.

Market Cap11.04B
Enterprise Value 7.01B

Important Dates

The last earnings date was Wednesday, August 26, 2026.

Earnings Date Aug 26, 2026
Ex-Dividend Date Sep 8, 2026

Share Statistics

HKG:1681 has 839.05 million shares outstanding. The number of shares has decreased by -0.56% in one year.

Current Share Class 839.05M
Shares Outstanding 839.05M
Shares Change (YoY) -0.56%
Shares Change (QoQ) -0.77%
Owned by Insiders (%) 40.63%
Owned by Institutions (%) 26.47%
Float 456.13M

Valuation Ratios

The trailing PE ratio is 8.26 and the forward PE ratio is 7.69.

PE Ratio 8.26
Forward PE 7.69
PS Ratio 2.63
PB Ratio 1.89
P/TBV Ratio 2.13
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 5.17
EV / Sales 1.67
EV / EBITDA 4.48
EV / EBIT 4.67
EV / FCF n/a

Financial Position

The company has a current ratio of 2.91, with a Debt / Equity ratio of 0.05.

Current Ratio 2.91
Quick Ratio 2.71
Debt / Equity 0.05
Debt / EBITDA 0.17
Debt / FCF n/a
Interest Coverage 284.05

Financial Efficiency

Return on equity (ROE) is 24.40% and return on invested capital (ROIC) is 89.25%.

Return on Equity (ROE) 24.40%
Return on Assets (ROA) 12.58%
Return on Invested Capital (ROIC) 89.25%
Return on Capital Employed (ROCE) 24.89%
Weighted Average Cost of Capital (WACC) 6.75%
Revenue Per Employee 1.47M
Profits Per Employee 476,499
Employee Count2,847
Asset Turnover 0.56
Inventory Turnover 2.45

Taxes

In the past 12 months, HKG:1681 has paid 202.14 million in taxes.

Income Tax 202.14M
Effective Tax Rate 12.88%

Stock Price Statistics

The stock price has decreased by -17.99% in the last 52 weeks. The beta is 0.48, so HKG:1681's price volatility has been lower than the market average.

Beta (5Y) 0.48
52-Week Price Change -17.99%
50-Day Moving Average 13.63
200-Day Moving Average 15.28
Relative Strength Index (RSI) 41.07
Average Volume (20 Days) 2,106,148

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:1681 had revenue of HKD 4.19 billion and earned 1.36 billion in profits. Earnings per share was 1.59.

Revenue4.19B
Gross Profit 3.36B
Operating Income 1.50B
Pretax Income 1.57B
Net Income 1.36B
EBITDA 1.57B
EBIT 1.50B
Earnings Per Share (EPS) 1.59
Full Income Statement

Balance Sheet

The company has 4.64 billion in cash and 264.92 million in debt, with a net cash position of 4.38 billion or 5.22 per share.

Cash & Cash Equivalents 4.64B
Total Debt 264.92M
Net Cash 4.38B
Net Cash Per Share 5.22
Equity (Book Value) 5.84B
Book Value Per Share 6.55
Working Capital 3.53B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Depreciation & Amortization 64.42M
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 80.10%, with operating and profit margins of 35.80% and 32.34%.

Gross Margin 80.10%
Operating Margin 35.80%
Pretax Margin 37.42%
Profit Margin 32.34%
EBITDA Margin 37.32%
EBIT Margin 35.80%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 5.91%.

Dividend Per Share 0.80
Dividend Yield 5.91%
Dividend Growth (YoY) 23.81%
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.56%
Shareholder Yield 6.47%
Earnings Yield 12.29%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Analyst Forecast

The average price target for HKG:1681 is 22.90, which is 75.61% higher than the current price. The consensus rating is "Buy".

Price Target 22.90
Price Target Difference 75.61%
Analyst Consensus Buy
Analyst Count 3
Revenue Growth Forecast (3Y) 12.47%
EPS Growth Forecast (3Y) 13.29%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3